[1]
Kara, O. 2022. Ganciclovir in the Prevention of Cytomegalovirus Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation: Non-Eliminative Reduction of Viral Load. Medical Science and Discovery. 9, 7 (Jul. 2022), 401–405. DOI:https://doi.org/10.36472/msd.v9i7.761.